Ginkgo Bioworks (DNA) Misses Q3 EPS by 12c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.41), $0.12 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $66.4 million versus the consensus estimate of $60.35 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Carvana (CVNA) PT Lowered to $85 at RBC Capital
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c